232 related articles for article (PubMed ID: 36769163)
21. Natural and Synthetic Coumarins with Effects on Inflammation.
Kirsch G; Abdelwahab AB; Chaimbault P
Molecules; 2016 Oct; 21(10):. PubMed ID: 27706093
[TBL] [Abstract][Full Text] [Related]
22. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors.
Ng TB; Huang B; Fong WP; Yeung HW
Life Sci; 1997; 61(10):933-49. PubMed ID: 9296332
[TBL] [Abstract][Full Text] [Related]
23. In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse model.
Xu ZQ; Hollingshead MG; Borgel S; Elder C; Khilevich A; Flavin MT
Bioorg Med Chem Lett; 1999 Jan; 9(2):133-8. PubMed ID: 10021914
[TBL] [Abstract][Full Text] [Related]
24. Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.
Esposito F; Ambrosio FA; Maleddu R; Costa G; Rocca R; Maccioni E; Catalano R; Romeo I; Eleftheriou P; Karia DC; Tsirides P; Godvani N; Pandya H; Corona A; Alcaro S; Artese A; Geronikaki A; Tramontano E
Eur J Med Chem; 2019 Nov; 182():111617. PubMed ID: 31442684
[TBL] [Abstract][Full Text] [Related]
25. New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii.
McKee TC; Fuller RW; Covington CD; Cardellina JH; Gulakowski RJ; Krepps BL; McMahon JB; Boyd MR
J Nat Prod; 1996 Aug; 59(8):754-8. PubMed ID: 8792623
[TBL] [Abstract][Full Text] [Related]
26. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
Hu Z; Kuritzkes DR
J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
[TBL] [Abstract][Full Text] [Related]
27. Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers.
Eiznhamer DA; Creagh T; Ruckle JL; Tolbert DT; Giltner J; Dutta B; Flavin MT; Jenta T; Xu ZQ
HIV Clin Trials; 2002; 3(6):435-50. PubMed ID: 12501127
[TBL] [Abstract][Full Text] [Related]
28. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors.
Taylor PB; Culp JS; Debouck C; Johnson RK; Patil AD; Woolf DJ; Brooks I; Hertzberg RP
J Biol Chem; 1994 Mar; 269(9):6325-31. PubMed ID: 7509800
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomers.
Flavin MT; Rizzo JD; Khilevich A; Kucherenko A; Sheinkman AK; Vilaychack V; Lin L; Chen W; Greenwood EM; Pengsuparp T; Pezzuto JM; Hughes SH; Flavin TM; Cibulski M; Boulanger WA; Shone RL; Xu ZQ
J Med Chem; 1996 Mar; 39(6):1303-13. PubMed ID: 8632437
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors.
Olomola TO; Klein R; Mautsa N; Sayed Y; Kaye PT
Bioorg Med Chem; 2013 Apr; 21(7):1964-71. PubMed ID: 23415084
[TBL] [Abstract][Full Text] [Related]
31. [Anti-HIV-1 activity and structure-activity relationship of pyranocoumarin analogs].
Dong B; Ma T; Zhang T; Zhou CM; Liu G; Wang L; Tao PZ; Zhang XQ
Yao Xue Xue Bao; 2011 Jan; 46(1):35-8. PubMed ID: 21465806
[TBL] [Abstract][Full Text] [Related]
32. [Anti-HIV activities of HIV-1 reverse transcriptase inhibitor racemic 11-demethyl-calanolide A].
Peng ZG; Chen HS; Wang L; Liu G
Yao Xue Xue Bao; 2008 May; 43(5):456-60. PubMed ID: 18717330
[TBL] [Abstract][Full Text] [Related]
33. Discovery, optimization, and target identification of novel coumarin derivatives as HIV-1 reverse transcriptase-associated ribonuclease H inhibitors.
Kang D; Urhan Ç; Wei F; Frutos-Beltrán E; Sun L; Álvarez M; Feng D; Tao Y; Pannecouque C; De Clercq E; Menéndez-Arias L; Liu X; Zhan P
Eur J Med Chem; 2021 Dec; 225():113769. PubMed ID: 34403976
[TBL] [Abstract][Full Text] [Related]
34. Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase.
Zhu M; Ma L; Wen J; Dong B; Wang Y; Wang Z; Zhou J; Zhang G; Wang J; Guo Y; Liang C; Cen S; Wang Y
Eur J Med Chem; 2020 Jan; 186():111900. PubMed ID: 31771827
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HIV-1 reverse transcription: basic principles of drug action and resistance.
Götte M
Expert Rev Anti Infect Ther; 2004 Oct; 2(5):707-16. PubMed ID: 15482234
[TBL] [Abstract][Full Text] [Related]
36. Calanolide A: a natural non-nucleoside reverse transcriptase inhibitor.
Hanna L
BETA; 1999 Apr; 12(2):8-9. PubMed ID: 11366704
[TBL] [Abstract][Full Text] [Related]
37. The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A.
Auwerx J; Rodríguez-Barrios F; Ceccherini-Silberstein F; San-Félix A; Velázquez S; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
Mol Pharmacol; 2005 Sep; 68(3):652-9. PubMed ID: 15961674
[TBL] [Abstract][Full Text] [Related]
38. Plant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirus.
Xu ZQ; Kern ER; Westbrook L; Allen LB; Buckheit RW; Tseng CK; Jenta T; Flavin MT
Antivir Chem Chemother; 2000 Jan; 11(1):23-9. PubMed ID: 10693651
[TBL] [Abstract][Full Text] [Related]
39. Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication.
Rawle DJ; Li D; Wu Z; Wang L; Choong M; Lor M; Reid RC; Fairlie DP; Harris J; Tachedjian G; Poulsen SA; Harrich D
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918071
[TBL] [Abstract][Full Text] [Related]
40. Prenylated Coumarins from the Fruits of
Liu YP; Yan G; Guo JM; Liu YY; Li YJ; Zhao YY; Qiang L; Fu YH
J Agric Food Chem; 2019 Oct; 67(43):11942-11947. PubMed ID: 31622090
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
